Placing both CD28 and 41BB costimulatory domains upstream of CD3ζ in third-generation CAR T cells demonstrated variable results: some showed improved expansion, cytokine production and anti-tumor function, while others had inferior activity in comparison to second generation CARs [68,69]. Here, CD28 is linked to neoplasm.